LAG3 and neoplasm: Tumor-infiltrating effector CD8 T cells were identified as drivers of LAG3, TNFSF9, and HAVCR2 overexpression, which suggests effector CD8 TILs are activated and exhausted relative to circulating leukocytes, a finding that is consistent with reports across multiple human tumor types [8, 9].